(RTTNews) - Mainz Biomed NV (MYNZ), a molecular genetics diagnostic company, on Tuesday announced the launch of the eAArly DETECT 2 feasibility study to evaluate its next-generation colorectal cancer ...

A recent study by Oakland, Calif.-based Kaiser Permanente found that antibiotics use is unlikely to be a factor in the increase in CRC diagnosis in adults under 50. The study, published in Clinical ...

A proof-of-concept formative trial evaluating the interest of multiple connected devices for the early detection of hand-foot skin reactions in patients treated with regorafenib therapy (FACET).

Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The FIND-CRC study, officially titled ...

Natera Inc. ((NTRA)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: The PROCEED-CRC study, ...